30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Biotechnology & Medical Research

Hemogenyx Pharmaceuticals PLC (HEMO)

Track

The most recent insider trading activity occurred on May 27, 2022, with a BUY transaction by Andrew Wright, Financial Controller and Company Secretary, for 1,284,889 shares valued at $18,502.4. Prior to this, Mr. Wright made several other BUY transactions dating back to January 2020. Earlier transactions include BUYs by Adrian Beeston and Vladislav Sandler in February 2018.
Stock chart
Ticker: HEMO Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Andrew Wright
Financial Controller and Company Secretary
1 purchase — total 18,502 GBP
Buy 27 May 2022
Value £4,943,842.95 | Price 152.05 | Shares 68,675
Buy 18 May 2021
Value £2,874,047.90 | Price 98.70 | Shares 25,544
Buy 8 Mar 2021
Value £5,721.38 | Price 0.06 | Shares 94,882
Buy 29 Jun 2020
Value £19,891.53 | Price 0.06 | Shares 344,150
Through Olena Wright, a closely affiliated person
Buy 29 Jun 2020
Value £5,143.38 | Price 0.06 | Shares 90,554
Buy 30 Jan 2020
Value £4,999.99 | Price 0.02 | Shares 257,069
Buy 30 Apr 2019
Value £20,000.00 | Price 0.02 | Shares 840,336
Buy 9 Feb 2018
Value £4,200.00 | Price 0.02 | Shares 200,000
Buy 5 Feb 2018
Value £635.16 | Price 0.02 | Shares 26,800
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-30 2022-05-27 B Purchase Andrew Wright

Financial Controller and Company Secretary
68,675
152.05
£4,943,843 		68,675 152.05 £4,943,843
2021-05-19 2021-05-18 B Purchase Andrew Wright

Financial Controller and Company Secretary
25,544
98.70
£2,874,048 		25,544 98.70 £2,874,048
2021-03-09 2021-03-08 B Purchase Andrew Wright

Financial Controller and Company Secretary
57,233
125.70
£2,907,463 		57,233 125.70 £2,907,463
2020-06-30 2020-06-29 B Purchase Andrew Wright

Financial Controller and Company Secretary

Through Olena Wright, a closely affiliated person
344,150
0.06
£19,892 		344,150 0.06 £19,892
2020-06-30 2020-06-29 B Purchase Andrew Wright

Financial Controller and Company Secretary
90,554
0.06
£5,143 		90,554 0.06 £5,143
2020-01-31 2020-01-30 B Purchase Andrew Wright

Financial Controller and Company Secretary
257,069
0.02
£5,000 		257,069 0.02 £5,000
2019-05-01 2019-04-30 B Purchase Andrew Wright

Financial Controller and Company Secretary
840,336
0.02
£20,000 		840,336 0.02 £20,000
2018-02-12 2018-02-09 B Purchase Adrian Beeston

Non-executive Director

Executive Director
200,000
0.02
£4,200 		200,000 0.02 £4,200
2018-02-07 2018-02-05 B Purchase Vladislav Sandler

Chief Executive Officer and Co-Founder

Officer
26,800
0.02
£635 		26,800 0.02 £635
Explore more

More insider trading research around Hemogenyx Pharmaceuticals PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe